[144] IBEX Ltd SEC Filing

Rhea-AI Filing Summary

IBEX Ltd filed a Form 144 notifying a proposed sale of 697 common shares with an aggregate market value of $27,587.95, scheduled approximately for 10/02/2025. The filing shows 13,315,077 shares outstanding for the issuer and states the 697 shares were acquired on 09/30/2025 by vesting of a performance grant (2,347 shares noted as granted and vested on that date).

The filing also discloses prior sales by Paul Joseph Inson within the past three months: 10,000 shares on 08/22/2025 for $300,013.00, 255 shares on 08/26/2025 for $7,428.15, and 3,831 shares on 09/12/2025 for $149,179.14. The filer certifies no undisclosed material adverse information is known.

Positive

• Form 144 filed, indicating procedural compliance for proposed insider sale
• Proposed sale of 697 shares is small relative to 13,315,077 shares outstanding

Negative

• Insider sales of 14,086 shares in the past three months generating $456,620.29
• Vesting-based acquisition on 09/30/2025 may indicate insiders are realizing compensation-derived shares

Insights

Corporate Securities Attorney

Form 144 documents a planned insider sale and recent insider disposals.

The filing records a proposed sale of 697 shares valued at $27,587.95 and confirms acquisition by vesting of a performance grant on 09/30/2025, which is relevant to Rule 144 timing and holding-period considerations.

This notice and the listed prior sales on 08/22/2025, 08/26/2025, and 09/12/2025 show compliance steps required for exempt distributions; the signature representation about lack of undisclosed material information is a standard legal attestation in these filings.

Equity Capital Markets Analyst

Insider selling activity is visible but the proposed sale size is small relative to shares outstanding.

The proposed 697-share sale equals ~0.0052% of the reported 13,315,077 shares outstanding, indicating the immediate proposed sale is immaterial to market cap.

However, disclosed prior sales totaled $456,620.29 across three transactions in the past three months, which investors may note as recent insider liquidity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	GLOBAL SHARES FINANCIAL SERVICES INC. 575 WASHINGTON BLVD FLOOR 9 JERSEY CITY NJ 07310-1616	697	27587.95	13315077	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	09/30/2025	VESTING OF PERFORMANCE GRANT	ISSUER			2347	09/30/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PAUL JOSEPH INSON c/o IBEX LIMITED 1717 Pennsylvania Avenue NW, Suite 825 Washington DC 20006	COMMON	08/22/2025	10000	300013.00
PAUL JOSEPH INSON c/o IBEX LIMITED 1717 Pennsylvania Avenue NW, Suite 825 Washington DC 20006	COMMON	08/26/2025	255	7428.15
PAUL JOSEPH INSON c/o IBEX LIMITED 1717 Pennsylvania Avenue NW, Suite 825 Washington DC 20006	COMMON	09/12/2025	3831	149179.14

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does IBEX's Form 144 filed on 10/02/2025 disclose?

It notifies a proposed sale of 697 common shares valued at $27,587.95, with an approximate sale date of 10/02/2025.

How were the 697 shares acquired according to the filing?

The filing shows the shares were acquired by vesting of a performance grant on 09/30/2025.

How many IBEX shares were outstanding per the Form 144?

The filing lists 13,315,077 shares outstanding.

What insider sales did the filing disclose in the past three months?

Sales by Paul Joseph Inson: 10,000 shares on 08/22/2025 for $300,013.00, 255 shares on 08/26/2025 for $7,428.15, and 3,831 shares on 09/12/2025 for $149,179.14.

Does the filer claim any undisclosed material information?

By signing, the person represents they do not know any material adverse information about the issuer that is not publicly disclosed.